The global point of care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4% during the forecast period. The global point of care diagnostics market offers significant growth potential for prominent as well as emerging product manufacturers. Technological advancements in POC devices, rising incidence of infectious dieases, and increase in the investments by key players are key factors driving the growth of the point of care diagnostics market.
 |
| Point Of Care Diagnostics Market |
The
point-of-care diagnostics market will witness significant growth in 2020, owing
to the increasing usage of POC tests that can rapidly diagnose COVID-19. With
the increase in the demand for speedy diagnostic results, the adoption of point
of-care testing is booming. The rapidly growing number of COVID-19 cases and
the growing pressure on governments to improve patient management has boosted
the demand for rapid antigen testing kits that can be effectively used in
point-of-care settings.Such rapidly detecting tool are vital in providing accurate
treatment option.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185
Market Leaders:
·
Roche Diagnostics (Switzerland),
·
Siemens Healthineers (Germany),
·
Danaher Corporation (US),
·
Becton Dickinson and Company (US),
·
Abbott Laboratories (US),
·
Quidel Diagnostics (US),
·
Chembio Diagnostics (US) and many more……
Geographic Analysis:
North
America (comprising the US and Canada) dominates point of care diagnostics
market. North America is a gaining traction with the increasing incidence and
prevalence of lifestyle diseases. Moreoer resence of major key platers in the
region, facourable government scenarios, higher awarness of self tetsing and
home care products and significant adoption of novel technologies are likely to
paly a major role in fueling the growth of the point of care diagnostics market
in the North America.
Comments
Post a Comment